Posted on: 13 March, 2023
With ovarian cancer continuing to have a devastating outcome for many women, new research at the Kolling Institute is offering hope.
The disease has the lowest survival rate of any women’s cancer, with only 48 per cent of women living beyond five years after diagnosis.
Ovarian cancer is often diagnosed late because the symptoms are vague, like bloating, nausea, indigestion, excessive tir.....
Category: New Treatment, Research Excellence
Posted on: 27 February, 2023
Kolling Institute Governance Committee Chair Michael Nugent said it is encouraging to see more than a dozen researchers from the Kolling have been profiled in an international study recognising the world’s best.
Published by Stanford University, the study has identified the top two per cent of researchers in the world across individual fields.
The study is based on metrics from Scopus, a.....
Category: Research Excellence
Posted on: 20 February, 2023
A collection of emerging research leaders will have the chance to broaden their research experience thanks to funding provided through the Skipper Jacobs Charitable Trust.
Close to $40,000 will be shared amongst five early-to-mid career researchers, allowing them to travel nationally and internationally expanding their research and developing new skills.
It’s anticipated the travel progr.....
Category: Awards, Research Excellence
Posted on: 14 February, 2023
We are pleased to announce the successful recipients of our annual Kolling Institute awards program.
Launched in 2021, the program has been expanded to acknowledge a greater number of researchers and their individual contribution to the Kolling.
The awards aim to recognise the many outstanding achievements across education, clinical practice and service, publications, research, as well a.....
Category: Awards, Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research
Posted on: 04 March, 2022
Researchers from the Kolling Institute and Royal North Shore Hospital will help drive a new project investigating a revolutionary approach to care for those with neuroendocrine tumours.
Cancer specialists Professor Nick Pavlakis and Dr David Chan will join the AUS-NET trial after a funding announcement by Health Minister Greg Hunt.
The study will assess whether a new patient-specific car.....
Category: Funding support, Research Excellence
Posted on: 28 February, 2022
The Cancer Council NSW today announced funding for a new stem cell team at the Kolling Institute to examine a revolutionary approach to treatment for those with acute myeloid leukaemia.
This aggressive form of blood cancer has a tragically poor survival rate, and while we have seen tremendous progress for many other types of cancer in recent years, there have been very limited improvemen.....
Category: Funding support, Research Excellence
Posted on: 09 February, 2022
The Kolling is set to be one of the first institutes in New South Wales to introduce new world-leading technology, boosting our cancer and neuroscience research capabilities.
The Digital Spatial Profiling System has been made possible following a $535,000 grant from the Australian Research Council LIEF scheme. The project is being co-funded by the University of Sydney with a $250,000 con.....
Category: Research Excellence, World-leading technology
Posted on: 15 December, 2021
Acting Executive Director Professor Jim Elliott has announced the winners of the inaugural Kolling Institute Emerging Leader Awards, saying there’s an inspiring depth of expertise throughout the institute.
Professor Elliott said the new awards recognise our young leaders across our basic and translational research, and were initiated by the institute’s Workforce and Culture Enabler Commi.....
Posted on: 07 May, 2021
An exciting project between the University of Sydney and the Northern Sydney Local Health District will see a $15 million, revolutionary scanner installed at Royal North Shore Hospital, greatly improving patient care and research capabilities.
Australia’s first Total Body Positron Emission Tomography (TB-PET) scanner will produce faster and higher quality whole-body PET/CT scans, with l.....
Category: World-leading technology
Posted on: 10 December, 2020
The Kolling’s Dr Amanda Hudson will lead an exciting pilot study after being awarded an innovation grant by the Mark Hughes Foundation for brain cancer research.
The Bill Walsh Lab scientist is one of a select group to have received funding from the foundation. Her research will now investigate the early detection of disease progression in brain cancer.
Dr Hudson said identifying changes.....
Category: Funding support, Neuroscience and Pain Research